Blocking a receptor involved in prostaglandins reduces pain while allowing inflammation to proceed normally, according to findings from animal and cell studies. Researchers at the NYU Pain Research ...

An international research group directed by UMC Utrecht have developed and characterized two first-in-class antibodies that ...

An international team of researchers led by UMC Utrecht has developed two new antibodies that can cleverly inhibit the immune ...

Akeso, Inc. (HKEX: 9926.HK) announced that its AK152, a novel bispecific antibody targeting both amyloid-beta (Aβ) and blood-brain barrier (BBB) expressed receptor, has been granted approval by the ...

The researchers captured eight unique structural models and 16 cryogenic electron microscopy maps of the receptor with both ...

Gynecological cancers remain a major threat to women's health, with traditional therapies often having limited effect and ...

Experiments in three therapeutic cancer vaccine mouse models, conducted by investigators at the Vaccine Branch of the National Cancer Institute in Bethesda, Maryland, support the conclusion that ...

Autoimmunity BioSolutions (ABS), is pioneering a personalized, genetically guided immuno-corrective therapy designed to ...

New research from the University of Eastern Finland sheds light on the significance of the glucocorticoid receptor in drug-resistant prostate cancer, showing that the development of drug resistance ...

Akeso, Inc. (HKEX: 9926.HK) announced that its AK152, a novel bispecific antibody targeting both amyloid-beta (Aß) and blood-brain barrier (BBB) expressed receptor, has been granted ...